{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:21:12Z","timestamp":1778224872973,"version":"3.51.4"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T00:00:00Z","timestamp":1324512000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Mol Cell Biol"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/nrm3254","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T10:44:40Z","timestamp":1324550680000},"page":"27-38","source":"Crossref","is-referenced-by-count":1017,"title":["Building strong bones: molecular regulation of the osteoblast lineage"],"prefix":"10.1038","volume":"13","author":[{"given":"Fanxin","family":"Long","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,12,22]]},"reference":[{"key":"BFnrm3254_CR1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrendo.2009.196","volume":"5","author":"MS Razzaque","year":"2009","unstructured":"Razzaque, M. S. The FGF23\u2013Klotho axis: endocrine regulation of phosphate homeostasis. Nature Rev. Endocrinol. 5, 611\u2013619 (2009).","journal-title":"Nature Rev. Endocrinol."},{"key":"BFnrm3254_CR2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841\u2013846 (2003).","journal-title":"Nature"},{"key":"BFnrm3254_CR3","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nature02041","volume":"425","author":"J Zhang","year":"2003","unstructured":"Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836\u2013841 (2003).","journal-title":"Nature"},{"key":"BFnrm3254_CR4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2005.05.026","volume":"121","author":"MJ Kiel","year":"2005","unstructured":"Kiel, M. J., Yilmaz, O. H., Iwashita, T., Terhorst, C. & Morrison, S. J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109\u20131121 (2005).","journal-title":"Cell"},{"key":"BFnrm3254_CR5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","volume":"25","author":"T Sugiyama","year":"2006","unstructured":"Sugiyama, T., Kohara, H., Noda, M. & Nagasawa, T. Maintenance of the hematopoietic stem cell pool by CXCL12\u2013CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25, 977\u2013988 (2006).","journal-title":"Immunity"},{"key":"BFnrm3254_CR6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","volume":"142","author":"M Ferron","year":"2010","unstructured":"Ferron, M. et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142, 296\u2013308 (2010).","journal-title":"Cell"},{"key":"BFnrm3254_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cell.2010.06.002","volume":"142","author":"K Fulzele","year":"2010","unstructured":"Fulzele, K. et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142, 309\u2013319 (2010).","journal-title":"Cell"},{"key":"BFnrm3254_CR8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.cell.2011.02.004","volume":"144","author":"F Oury","year":"2011","unstructured":"Oury, F. et al. Endocrine regulation of male fertility by the skeleton. Cell 144, 796\u2013809 (2011).","journal-title":"Cell"},{"key":"BFnrm3254_CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/B978-012319060-4\/50004-X","volume-title":"Bone and Cartilage: Developmental Skeletal Biology","author":"BK Hall","year":"2005","unstructured":"Hall, B. K. in Bone and Cartilage: Developmental Skeletal Biology 13\u201330 (Elsevier Academic Press, 2005)."},{"key":"BFnrm3254_CR10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1083\/jcb.11.3.627","volume":"11","author":"HR Dudley","year":"1961","unstructured":"Dudley, H. R. & Spiro, D. The fine structure of bone cells. J. Biophys. Biochem. Cytol. 11, 627\u2013649 (1961).","journal-title":"J. Biophys. Biochem. Cytol."},{"key":"BFnrm3254_CR11","first-page":"259","volume":"86","author":"JJ Pritchard","year":"1952","unstructured":"Pritchard, J. J. A cytological and histochemical study of bone and cartilage formation in the rat. J. Anat. 86, 259\u2013277 (1952).","journal-title":"J. Anat."},{"key":"BFnrm3254_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1083\/jcb.19.1.19","volume":"19","author":"M Owen","year":"1963","unstructured":"Owen, M. Cell population kinetics of an osteogenic tissue. I. J. Cell Biol. 19, 19\u201332 (1963).","journal-title":"J. Cell Biol."},{"key":"BFnrm3254_CR13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1083\/jcb.19.1.33","volume":"19","author":"M Owen","year":"1963","unstructured":"Owen, M. & Macpherson, S. Cell population kinetics of an osteogenic tissue. II. J. Cell Biol. 19, 33\u201344 (1963).","journal-title":"J. Cell Biol."},{"key":"BFnrm3254_CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","volume":"26","author":"LF Bonewald","year":"2011","unstructured":"Bonewald, L. F. The amazing osteocyte. J. Bone Miner. Res. 26, 229\u2013238 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","volume":"199","author":"RL van Bezooijen","year":"2004","unstructured":"van Bezooijen, R. L. et al. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 199, 805\u2013814 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrm3254_CR16","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","volume":"146","author":"T Bellido","year":"2005","unstructured":"Bellido, T. et al. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146, 4577\u20134583 (2005).","journal-title":"Endocrinology"},{"key":"BFnrm3254_CR17","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","volume":"283","author":"AG Robling","year":"2008","unstructured":"Robling, A. G. et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost\/sclerostin. J. Biol. Chem. 283, 5866\u20135875 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3254_CR18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","volume":"37","author":"H Keller","year":"2005","unstructured":"Keller, H. & Kneissel, M. SOST is a target gene for PTH in bone. Bone 37, 148\u2013158 (2005).","journal-title":"Bone"},{"key":"BFnrm3254_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/JOE-10-0308","volume":"209","author":"WF Powell Jr.","year":"2011","unstructured":"Powell, W. F. Jr. et al. Targeted ablation of the PTH\/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J. Endocrinol. 209, 21\u201332 (2011).","journal-title":"J. Endocrinol."},{"key":"BFnrm3254_CR20","doi-asserted-by":"crossref","first-page":"41614","DOI":"10.1074\/jbc.M110.153890","volume":"285","author":"C Krause","year":"2010","unstructured":"Krause, C. et al. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J. Biol. Chem. 285, 41614\u201341626 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3254_CR21","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","volume":"280","author":"X Li","year":"2005","unstructured":"Li, X. et al. Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280, 19883\u201319887 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3254_CR22","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","volume":"280","author":"M Semenov","year":"2005","unstructured":"Semenov, M., Tamai, K. & He, X. SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem. 280, 26770\u201326775 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3254_CR23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.cellbio.16.1.191","volume":"16","author":"BR Olsen","year":"2000","unstructured":"Olsen, B. R., Reginato, A. M. & Wang, W. Bone development. Annu. Rev. Cell Dev. Biol. 16, 191\u2013220 (2000).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFnrm3254_CR24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature01657","volume":"423","author":"HM Kronenberg","year":"2003","unstructured":"Kronenberg, H. M. Developmental regulation of the growth plate. Nature 423, 332\u2013336 (2003).","journal-title":"Nature"},{"key":"BFnrm3254_CR25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2010.07.010","volume":"19","author":"C Maes","year":"2010","unstructured":"Maes, C. et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev. Cell 19, 329\u2013344 (2010).","journal-title":"Dev. Cell"},{"key":"BFnrm3254_CR26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","volume":"19","author":"P Bianco","year":"2001","unstructured":"Bianco, P., Riminucci, M., Gronthos, S. & Robey, P. G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19, 180\u2013192 (2001).","journal-title":"Stem Cells"},{"key":"BFnrm3254_CR27","first-page":"19","volume":"25","author":"AJ Friedenstein","year":"1980","unstructured":"Friedenstein, A. J. Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo. Haematol. Blood Transfus. 25, 19\u201329 (1980).","journal-title":"Haematol. Blood Transfus."},{"key":"BFnrm3254_CR28","first-page":"42","volume":"136","author":"M Owen","year":"1988","unstructured":"Owen, M. & Friedenstein, A. J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found. Symp. 136, 42\u201360 (1988).","journal-title":"Ciba Found. Symp."},{"key":"BFnrm3254_CR29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143\u2013147 (1999).","journal-title":"Science"},{"key":"BFnrm3254_CR30","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1359\/jbmr.1997.12.9.1335","volume":"12","author":"SA Kuznetsov","year":"1997","unstructured":"Kuznetsov, S. A. et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12, 1335\u20131347 (1997).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2007.08.025","volume":"131","author":"B Sacchetti","year":"2007","unstructured":"Sacchetti, B. et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324\u2013336 (2007).","journal-title":"Cell"},{"key":"BFnrm3254_CR32","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1084\/jem.20091046","volume":"206","author":"S Morikawa","year":"2009","unstructured":"Morikawa, S. et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J. Exp. Med. 206, 2483\u20132496 (2009).","journal-title":"J. Exp. Med."},{"key":"BFnrm3254_CR33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"Mendez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829\u2013834 (2010).","journal-title":"Nature"},{"key":"BFnrm3254_CR34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2008.03.002","volume":"2","author":"P Bianco","year":"2008","unstructured":"Bianco, P., Robey, P. G. & Simmons, P. J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313\u2013319 (2008).","journal-title":"Cell Stem Cell"},{"key":"BFnrm3254_CR35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm3049","volume":"12","author":"C Nombela-Arrieta","year":"2011","unstructured":"Nombela-Arrieta, C., Ritz, J. & Silberstein, L. E. The elusive nature and function of mesenchymal stem cells. Nature Rev. Mol. Cell Biol. 12, 126\u2013131 (2011).","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnrm3254_CR36","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/jbmr.370","volume":"26","author":"RJ Pignolo","year":"2011","unstructured":"Pignolo, R. J. & Kassem, M. Circulating osteogenic cells: implications for injury, repair, and regeneration. J. Bone Miner. Res. 26, 1685\u20131693 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/8792","volume":"22","author":"W Bi","year":"1999","unstructured":"Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R. & de Crombrugghe, B. Sox9 is required for cartilage formation. Nature Genet. 22, 85\u201389 (1999).","journal-title":"Nature Genet."},{"key":"BFnrm3254_CR38","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1073\/pnas.111092198","volume":"98","author":"W Bi","year":"2001","unstructured":"Bi, W. et al. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl Acad. Sci. USA 98, 6698\u20136703 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/gene.10050","volume":"32","author":"R Kist","year":"2002","unstructured":"Kist, R., Schrewe, H., Balling, R. & Scherer, G. Conditional inactivation of Sox9: a mouse model for campomelic dysplasia. Genesis 32, 121\u2013123 (2002).","journal-title":"Genesis"},{"key":"BFnrm3254_CR40","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1101\/gad.1017802","volume":"16","author":"H Akiyama","year":"2002","unstructured":"Akiyama, H., Chaboissier, M. C., Martin, J. F., Schedl, A. & de Crombrugghe, B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16, 2813\u20132828 (2002).","journal-title":"Genes Dev."},{"key":"BFnrm3254_CR41","doi-asserted-by":"crossref","first-page":"14665","DOI":"10.1073\/pnas.0504750102","volume":"102","author":"H Akiyama","year":"2005","unstructured":"Akiyama, H. et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc. Natl Acad. Sci. USA 102, 14665\u201314670 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR42","doi-asserted-by":"crossref","first-page":"9360","DOI":"10.1073\/pnas.1631288100","volume":"100","author":"Y Mori-Akiyama","year":"2003","unstructured":"Mori-Akiyama, Y., Akiyama, H., Rowitch, D. H. & de Crombrugghe, B. Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc. Natl Acad. Sci. USA 100, 9360\u20139365 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR43","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","volume":"89","author":"T Komori","year":"1997","unstructured":"Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755\u2013764 (1997).","journal-title":"Cell"},{"key":"BFnrm3254_CR44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","volume":"89","author":"F Otto","year":"1997","unstructured":"Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765\u2013771 (1997).","journal-title":"Cell"},{"key":"BFnrm3254_CR45","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0092-8674(00)80260-3","volume":"89","author":"S Mundlos","year":"1997","unstructured":"Mundlos, S. et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773\u2013779 (1997).","journal-title":"Cell"},{"key":"BFnrm3254_CR46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ng0797-307","volume":"16","author":"B Lee","year":"1997","unstructured":"Lee, B. et al. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2\/CBFA1 in cleidocranial dysplasia. Nature Genet. 16, 307\u2013310 (1997).","journal-title":"Nature Genet."},{"key":"BFnrm3254_CR47","doi-asserted-by":"crossref","first-page":"8650","DOI":"10.1073\/pnas.151236498","volume":"98","author":"JY Choi","year":"2001","unstructured":"Choi, J. Y. et al. Subnuclear targeting of Runx\/Cbfa\/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl Acad. Sci. USA 98, 8650\u20138655 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR48","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1101\/gad.13.8.1025","volume":"13","author":"P Ducy","year":"1999","unstructured":"Ducy, P. et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13, 1025\u20131036 (1999).","journal-title":"Genes Dev."},{"key":"BFnrm3254_CR49","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1172\/JCI42528","volume":"120","author":"K Nishikawa","year":"2010","unstructured":"Nishikawa, K. et al. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J. Clin. Invest. 120, 3455\u20133465 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrm3254_CR50","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1110955","volume":"309","author":"JH Hong","year":"2005","unstructured":"Hong, J. H. et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074\u20131078 (2005).","journal-title":"Science"},{"key":"BFnrm3254_CR51","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/MCB.23.3.1004-1013.2003","volume":"23","author":"CB Cui","year":"2003","unstructured":"Cui, C. B., Cooper, L. F., Yang, X., Karsenty, G. & Aukhil, I. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol. Cell. Biol. 23, 1004\u20131013 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrm3254_CR52","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cell.2006.05.012","volume":"125","author":"G Dobreva","year":"2006","unstructured":"Dobreva, G. et al. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125, 971\u2013986 (2006).","journal-title":"Cell"},{"key":"BFnrm3254_CR53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/74231","volume":"24","author":"I Satokata","year":"2000","unstructured":"Satokata, I. et al. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nature Genet. 24, 391\u2013395 (2000).","journal-title":"Nature Genet."},{"key":"BFnrm3254_CR54","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1242\/dev.126.24.5699","volume":"126","author":"C Tribioli","year":"1999","unstructured":"Tribioli, C. & Lufkin, T. The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development 126, 5699\u20135711 (1999).","journal-title":"Development"},{"key":"BFnrm3254_CR55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1097-2765(01)00327-6","volume":"8","author":"DM Thomas","year":"2001","unstructured":"Thomas, D. M. et al. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell 8, 303\u2013316 (2001).","journal-title":"Mol. Cell"},{"key":"BFnrm3254_CR56","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nature09264","volume":"466","author":"E Calo","year":"2010","unstructured":"Calo, E. et al. Rb regulates fate choice and lineage commitment in vivo. Nature 466, 1110\u20131114 (2010).","journal-title":"Nature"},{"key":"BFnrm3254_CR57","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1091\/mbc.e06-08-0743","volume":"18","author":"A Shimoyama","year":"2007","unstructured":"Shimoyama, A. et al. Ihh\/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol. Biol. Cell 18, 2411\u20132418 (2007).","journal-title":"Mol. Biol. Cell"},{"key":"BFnrm3254_CR58","doi-asserted-by":"crossref","first-page":"35579","DOI":"10.1074\/jbc.M502267200","volume":"280","author":"MH Lee","year":"2005","unstructured":"Lee, M. H. et al. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J. Biol. Chem. 280, 35579\u201335587 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3254_CR59","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1101\/gad.988402","volume":"16","author":"RF Robledo","year":"2002","unstructured":"Robledo, R. F., Rajan, L., Li, X. & Lufkin, T. The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev. 16, 1089\u20131101 (2002).","journal-title":"Genes Dev."},{"key":"BFnrm3254_CR60","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1534-5807(04)00058-9","volume":"6","author":"P Bialek","year":"2004","unstructured":"Bialek, P. et al. A twist code determines the onset of osteoblast differentiation. Dev. Cell 6, 423\u2013435 (2004).","journal-title":"Dev. Cell"},{"key":"BFnrm3254_CR61","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1242\/dev.029355","volume":"136","author":"N Funato","year":"2009","unstructured":"Funato, N. et al. Hand2 controls osteoblast differentiation in the branchial arch by inhibiting DNA binding of Runx2. Development 136, 615\u2013625 (2009).","journal-title":"Development"},{"key":"BFnrm3254_CR62","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1101\/gad.1119303","volume":"17","author":"S Kim","year":"2003","unstructured":"Kim, S. et al. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev. 17, 1979\u20131991 (2003).","journal-title":"Genes Dev."},{"key":"BFnrm3254_CR63","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1126\/science.1126313","volume":"312","author":"DC Jones","year":"2006","unstructured":"Jones, D. C. et al. Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 312, 1223\u20131227 (2006).","journal-title":"Science"},{"key":"BFnrm3254_CR64","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1083\/jcb.201009107","volume":"191","author":"E Hesse","year":"2010","unstructured":"Hesse, E. et al. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J. Cell Biol. 191, 1271\u20131283 (2010).","journal-title":"J. Cell Biol."},{"key":"BFnrm3254_CR65","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1242\/dev.125.14.2587","volume":"125","author":"B Kanzler","year":"1998","unstructured":"Kanzler, B., Kuschert, S. J., Liu, Y. H. & Mallo, M. Hoxa-2 restricts the chondrogenic domain and inhibits bone formation during development of the branchial area. Development 125, 2587\u20132597 (1998).","journal-title":"Development"},{"key":"BFnrm3254_CR66","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature03940","volume":"437","author":"V Garg","year":"2005","unstructured":"Garg, V. et al. Mutations in NOTCH1 cause aortic valve disease. Nature 437, 270\u2013274 (2005).","journal-title":"Nature"},{"key":"BFnrm3254_CR67","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nm1716","volume":"14","author":"MJ Hilton","year":"2008","unstructured":"Hilton, M. J. et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nature Med. 14, 306\u2013314 (2008).","journal-title":"Nature Med."},{"key":"BFnrm3254_CR68","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.devcel.2008.03.007","volume":"14","author":"S Ohba","year":"2008","unstructured":"Ohba, S. et al. Patched1 haploinsufficiency increases adult bone mass and modulates Gli3 repressor activity. Dev. Cell 14, 689\u2013699 (2008).","journal-title":"Dev. Cell"},{"key":"BFnrm3254_CR69","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2004.10.024","volume":"119","author":"RB Vega","year":"2004","unstructured":"Vega, R. B. et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119, 555\u2013566 (2004).","journal-title":"Cell"},{"key":"BFnrm3254_CR70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","volume":"108","author":"K Nakashima","year":"2002","unstructured":"Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17\u201329 (2002).","journal-title":"Cell"},{"key":"BFnrm3254_CR71","doi-asserted-by":"crossref","first-page":"12919","DOI":"10.1073\/pnas.0912855107","volume":"107","author":"X Zhou","year":"2010","unstructured":"Zhou, X. et al. Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc. Natl Acad. Sci. USA 107, 12919\u201312924 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR72","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.200507106","volume":"172","author":"X Wang","year":"2006","unstructured":"Wang, X. et al. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J. Cell Biol. 172, 115\u2013125 (2006).","journal-title":"J. Cell Biol."},{"key":"BFnrm3254_CR73","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm1270","volume":"11","author":"T Koga","year":"2005","unstructured":"Koga, T. et al. NFAT and Osterix cooperatively regulate bone formation. Nature Med. 11, 880\u2013885 (2005).","journal-title":"Nature Med."},{"key":"BFnrm3254_CR74","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.devcel.2006.04.006","volume":"10","author":"MM Winslow","year":"2006","unstructured":"Winslow, M. M. et al. Calcineurin\/NFAT signaling in osteoblasts regulates bone mass. Dev. Cell 10, 771\u2013782 (2006).","journal-title":"Dev. Cell"},{"key":"BFnrm3254_CR75","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1083\/jcb.200412139","volume":"169","author":"VW Yu","year":"2005","unstructured":"Yu, V. W. et al. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice. J. Cell Biol. 169, 591\u2013601 (2005).","journal-title":"J. Cell Biol."},{"key":"BFnrm3254_CR76","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0092-8674(04)00344-7","volume":"117","author":"X Yang","year":"2004","unstructured":"Yang, X. et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin\u2013Lowry Syndrome. Cell 117, 387\u2013398 (2004).","journal-title":"Cell"},{"key":"BFnrm3254_CR77","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2006.10.010","volume":"4","author":"F Elefteriou","year":"2006","unstructured":"Elefteriou, F. et al. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab. 4, 441\u2013451 (2006).","journal-title":"Cell Metab."},{"key":"BFnrm3254_CR78","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature03398","volume":"434","author":"F Elefteriou","year":"2005","unstructured":"Elefteriou, F. et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434, 514\u2013520 (2005).","journal-title":"Nature"},{"key":"BFnrm3254_CR79","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2009.12.009","volume":"11","author":"E Ambrogini","year":"2010","unstructured":"Ambrogini, E. et al. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab. 11, 136\u2013146 (2010).","journal-title":"Cell Metab."},{"key":"BFnrm3254_CR80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cmet.2010.01.001","volume":"11","author":"MT Rached","year":"2010","unstructured":"Rached, M. T. et al. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 11, 147\u2013160 (2010).","journal-title":"Cell Metab."},{"key":"BFnrm3254_CR81","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1242\/dev.043281","volume":"136","author":"W Wang","year":"2009","unstructured":"Wang, W. et al. Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription. Development 136, 4143\u20134153 (2009).","journal-title":"Development"},{"key":"BFnrm3254_CR82","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1038\/sj.emboj.7600282","volume":"23","author":"R Eferl","year":"2004","unstructured":"Eferl, R. et al. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23, 2789\u20132799 (2004).","journal-title":"EMBO J."},{"key":"BFnrm3254_CR83","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/79676","volume":"6","author":"W Jochum","year":"2000","unstructured":"Jochum, W. et al. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nature Med. 6, 980\u2013984 (2000).","journal-title":"Nature Med."},{"key":"BFnrm3254_CR84","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1128\/MCB.24.7.2820-2830.2004","volume":"24","author":"M Kveiborg","year":"2004","unstructured":"Kveiborg, M. et al. \u0394FosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms. Mol. Cell. Biol. 24, 2820\u20132830 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrm3254_CR85","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/79683","volume":"6","author":"G Sabatakos","year":"2000","unstructured":"Sabatakos, G. et al. Overexpression of \u0394FosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nature Med. 6, 985\u2013990 (2000).","journal-title":"Nature Med."},{"key":"BFnrm3254_CR86","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1083\/jcb.200308155","volume":"164","author":"L Kenner","year":"2004","unstructured":"Kenner, L. et al. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J. Cell Biol. 164, 613\u2013623 (2004).","journal-title":"J. Cell Biol."},{"key":"BFnrm3254_CR87","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1101\/gad.938601","volume":"15","author":"PW Ingham","year":"2001","unstructured":"Ingham, P. W. & McMahon, A. P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15, 3059\u20133087 (2001).","journal-title":"Genes Dev."},{"key":"BFnrm3254_CR88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1242\/dev.124.1.113","volume":"124","author":"R Mo","year":"1997","unstructured":"Mo, R. et al. Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development 124, 113\u2013123 (1997).","journal-title":"Development"},{"key":"BFnrm3254_CR89","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1242\/dev.129.20.4753","volume":"129","author":"CB Bai","year":"2002","unstructured":"Bai, C. B., Auerbach, W., Lee, J. S., Stephen, D. & Joyner, A. L. Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. Development 129, 4753\u20134761 (2002).","journal-title":"Development"},{"key":"BFnrm3254_CR90","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1101\/gad.13.16.2072","volume":"13","author":"B St-Jacques","year":"1999","unstructured":"St-Jacques, B., Hammerschmidt, M. & McMahon, A. P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13, 2072\u20132086 (1999).","journal-title":"Genes Dev."},{"key":"BFnrm3254_CR91","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1242\/dev.01006","volume":"131","author":"F Long","year":"2004","unstructured":"Long, F. et al. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 131, 1309\u20131318 (2004).","journal-title":"Development"},{"issue":"1","key":"BFnrm3254_CR92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ydbio.2011.11.013","volume":"362","author":"Xiaolin Tu","year":"2012","unstructured":"Tu, X., Joeng, K. S. & Long, F. Indian hedgehog requires additional effectors besides Runx2 to induce osteoblast differentiation. Dev. Biol. 1 Dec 2011 (doi:10.1016\/j.ydbio.2011.11.013).","journal-title":"Developmental Biology"},{"key":"BFnrm3254_CR93","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1242\/dev.041624","volume":"136","author":"KS Joeng","year":"2009","unstructured":"Joeng, K. S. & Long, F. The Gli2 transcriptional activator is a crucial effector for Ihh signaling in osteoblast development and cartilage vascularization. Development 136, 4177\u20134185 (2009).","journal-title":"Development"},{"key":"BFnrm3254_CR94","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1242\/dev.02025","volume":"132","author":"MJ Hilton","year":"2005","unstructured":"Hilton, M. J., Tu, X., Cook, J., Hu, H. & Long, F. Ihh controls cartilage development by antagonizing Gli3, but requires additional effectors to regulate osteoblast and vascular development. Development 132, 4339\u20134351 (2005).","journal-title":"Development"},{"key":"BFnrm3254_CR95","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1073\/pnas.0608449104","volume":"104","author":"Y Maeda","year":"2007","unstructured":"Maeda, Y. et al. Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc. Natl Acad. Sci. USA 104, 6382\u20136387 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR96","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2008.01.027","volume":"13","author":"H Kimura","year":"2008","unstructured":"Kimura, H., Ng, J. M. & Curran, T. Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure. Cancer Cell 13, 249\u2013260 (2008).","journal-title":"Cancer Cell"},{"key":"BFnrm3254_CR97","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.devcel.2008.02.003","volume":"14","author":"KK Mak","year":"2008","unstructured":"Mak, K. K. et al. Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression. Dev. Cell 14, 674\u2013688 (2008).","journal-title":"Dev. Cell"},{"key":"BFnrm3254_CR98","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1101\/gad.836900","volume":"14","author":"R Kopan","year":"2000","unstructured":"Kopan, R. & Goate, A. A common enzyme connects notch signaling and Alzheimer's disease. Genes Dev. 14, 2799\u20132806 (2000).","journal-title":"Genes Dev."},{"key":"BFnrm3254_CR99","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1101\/gad.13.21.2801","volume":"13","author":"DB Donoviel","year":"1999","unstructured":"Donoviel, D. B. et al. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13, 2801\u20132810 (1999).","journal-title":"Genes Dev."},{"key":"BFnrm3254_CR100","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1073\/pnas.96.21.11872","volume":"96","author":"A Herreman","year":"1999","unstructured":"Herreman, A. et al. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl Acad. Sci. USA 96, 11872\u201311877 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR101","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/30756","volume":"393","author":"EH Schroeter","year":"1998","unstructured":"Schroeter, E. H., Kisslinger, J. A. & Kopan, R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382\u2013386 (1998).","journal-title":"Nature"},{"key":"BFnrm3254_CR102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2443.1996.10010.x","volume":"1","author":"T Honjo","year":"1996","unstructured":"Honjo, T. The shortest path from the surface to the nucleus: RBP-J\u03ba\/Su(H) transcription factor. Genes Cells 1, 1\u20139 (1996).","journal-title":"Genes Cells"},{"key":"BFnrm3254_CR103","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.bbrc.2006.05.046","volume":"345","author":"SA Mohamed","year":"2006","unstructured":"Mohamed, S. A. et al. Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve. Biochem. Biophys. Res. Commun. 345, 1460\u20131465 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrm3254_CR104","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng.779","volume":"43","author":"MA Simpson","year":"2011","unstructured":"Simpson, M. A. et al. Mutations in NOTCH2 cause Hajdu\u2013Cheney syndrome, a disorder of severe and progressive bone loss. Nature Genet. 43, 303\u2013305 (2011).","journal-title":"Nature Genet."},{"key":"BFnrm3254_CR105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng.778","volume":"43","author":"B Isidor","year":"2011","unstructured":"Isidor, B. et al. Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nature Genet. 43, 306\u2013308 (2011).","journal-title":"Nature Genet."},{"key":"BFnrm3254_CR106","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bone.2009.10.022","volume":"46","author":"R Salie","year":"2010","unstructured":"Salie, R. et al. Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone. Bone 46, 680\u2013694 (2010).","journal-title":"Bone"},{"key":"BFnrm3254_CR107","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1210\/en.2008-0140","volume":"149","author":"S Zanotti","year":"2008","unstructured":"Zanotti, S. et al. Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology 149, 3890\u20133899 (2008).","journal-title":"Endocrinology"},{"key":"BFnrm3254_CR108","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm1712","volume":"14","author":"F Engin","year":"2008","unstructured":"Engin, F. et al. Dimorphic effects of Notch signaling in bone homeostasis. Nature Med. 14, 299\u2013305 (2008).","journal-title":"Nature Med."},{"key":"BFnrm3254_CR109","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/jbmr.115","volume":"25","author":"J Tao","year":"2010","unstructured":"Tao, J. et al. Osteosclerosis owing to Notch gain of function is solely Rbpj-dependent. J. Bone Miner. Res. 25, 2175\u20132183 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR110","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/hmg\/ddp057","volume":"18","author":"F Engin","year":"2009","unstructured":"Engin, F. et al. Notch signaling contributes to the pathogenesis of human osteosarcomas. Hum. Mol. Genet. 18, 1464\u20131470 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrm3254_CR111","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0959-437X(00)00231-8","volume":"11","author":"J Huelsken","year":"2001","unstructured":"Huelsken, J. & Birchmeier, W. New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 11, 547\u2013553 (2001).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnrm3254_CR112","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1534-5807(03)00266-1","volume":"5","author":"MT Veeman","year":"2003","unstructured":"Veeman, M. T., Axelrod, J. D. & Moon, R. T. A second canon. Functions and mechanisms of \u03b2-catenin-independent Wnt signaling. Dev. Cell 5, 367\u2013377 (2003).","journal-title":"Dev. Cell"},{"key":"BFnrm3254_CR113","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cell.2008.01.052","volume":"133","author":"X Wu","year":"2008","unstructured":"Wu, X. et al. Rac1 activation controls nuclear localization of \u03b2-catenin during canonical Wnt signaling. Cell 133, 340\u2013353 (2008).","journal-title":"Cell"},{"key":"BFnrm3254_CR114","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","volume":"107","author":"Y Gong","year":"2001","unstructured":"Gong, Y. et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513\u2013523 (2001).","journal-title":"Cell"},{"key":"BFnrm3254_CR115","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","volume":"346","author":"LM Boyden","year":"2002","unstructured":"Boyden, L. M. et al. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346, 1513\u20131521 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrm3254_CR116","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/338450","volume":"70","author":"RD Little","year":"2002","unstructured":"Little, R. D. et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70, 11\u201319 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrm3254_CR117","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/MCB.25.12.4946-4955.2005","volume":"25","author":"M Ai","year":"2005","unstructured":"Ai, M., Holmen, S. L., Van Hul, W., Williams, B. O. & Warman, M. L. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol. Cell. Biol. 25, 4946\u20134955 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrm3254_CR118","doi-asserted-by":"crossref","first-page":"38276","DOI":"10.1074\/jbc.M609509200","volume":"281","author":"MV Semenov","year":"2006","unstructured":"Semenov, M. V. & He, X. LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J. Biol. Chem. 281, 38276\u201338284 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3254_CR119","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1359\/jbmr.060810","volume":"21","author":"DL Ellies","year":"2006","unstructured":"Ellies, D. L. et al. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J. Bone Miner. Res. 21, 1738\u20131749 (2006).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","volume":"10","author":"W Balemans","year":"2001","unstructured":"Balemans, W. et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 10, 537\u2013543 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrm3254_CR121","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","volume":"39","author":"W Balemans","year":"2002","unstructured":"Balemans, W. et al. Identification of a 52\u00a0kb deletion downstream of the SOST gene in patients with van Buchem disease. J. Med. Genet. 39, 91\u201397 (2002).","journal-title":"J. Med. Genet."},{"key":"BFnrm3254_CR122","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","volume":"68","author":"ME Brunkow","year":"2001","unstructured":"Brunkow, M. E. et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 68, 577\u2013589 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrm3254_CR123","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","volume":"110","author":"K Staehling-Hampton","year":"2002","unstructured":"Staehling-Hampton, K. et al. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. Am. J. Med. Genet. 110, 144\u2013152 (2002).","journal-title":"Am. J. Med. Genet."},{"key":"BFnrm3254_CR124","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1083\/jcb.200201089","volume":"157","author":"M Kato","year":"2002","unstructured":"Kato, M. et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157, 303\u2013314 (2002).","journal-title":"J. Cell Biol."},{"key":"BFnrm3254_CR125","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1073\/pnas.0408742102","volume":"102","author":"CN Bennett","year":"2005","unstructured":"Bennett, C. N. et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl Acad. Sci. USA 102, 3324\u20133329 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR126","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1359\/jbmr.040907","volume":"19","author":"SL Holmen","year":"2004","unstructured":"Holmen, S. L. et al. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J. Bone Miner. Res. 19, 2033\u20132040 (2004).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR127","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","volume":"17","author":"Y Cui","year":"2011","unstructured":"Cui, Y. et al. Lrp5 functions in bone to regulate bone mass. Nature Med. 17, 684\u2013691 (2011).","journal-title":"Nature Med."},{"key":"BFnrm3254_CR128","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","volume":"135","author":"VK Yadav","year":"2008","unstructured":"Yadav, V. K. et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135, 825\u2013837 (2008).","journal-title":"Cell"},{"key":"BFnrm3254_CR129","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"DA Glass 2nd.","year":"2005","unstructured":"Glass, D. A., 2nd. et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751\u2013764 (2005).","journal-title":"Dev. Cell"},{"key":"BFnrm3254_CR130","doi-asserted-by":"crossref","first-page":"21162","DOI":"10.1074\/jbc.M501900200","volume":"280","author":"SL Holmen","year":"2005","unstructured":"Holmen, S. L. et al. Essential role of \u03b2-catenin in postnatal bone acquisition. J. Biol. Chem. 280, 21162\u201321168 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3254_CR131","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00223-010-9350-7","volume":"86","author":"VK Yadav","year":"2010","unstructured":"Yadav, V. K., Arantes, H. P., Barros, E. R., Lazaretti-Castro, M. & Ducy, P. Genetic analysis of Lrp5 function in osteoblast progenitors. Calcif. Tissue Int. 86, 382\u2013388 (2010).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrm3254_CR132","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jbmr.376","volume":"26","author":"M Frost","year":"2011","unstructured":"Frost, M. et al. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J. Bone Miner. Res. 26, 1721\u20131728 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR133","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nm.2098","volume":"16","author":"VK Yadav","year":"2010","unstructured":"Yadav, V. K. et al. Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nature Med. 16, 308\u2013312 (2010).","journal-title":"Nature Med."},{"key":"BFnrm3254_CR134","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/jbmr.439","volume":"26","author":"H Inose","year":"2011","unstructured":"Inose, H. et al. Efficacy of serotonin inhibition in mouse models of bone loss. J. Bone Miner. Res. 26, 2002\u20132011 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1242\/dev.01564","volume":"132","author":"H Hu","year":"2005","unstructured":"Hu, H. et al. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132, 49\u201360 (2005).","journal-title":"Development"},{"key":"BFnrm3254_CR136","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1242\/dev.02480","volume":"133","author":"SJ Rodda","year":"2006","unstructured":"Rodda, S. J. & McMahon, A. P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133, 3231\u20133244 (2006).","journal-title":"Development"},{"key":"BFnrm3254_CR137","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.devcel.2005.03.016","volume":"8","author":"TF Day","year":"2005","unstructured":"Day, T. F., Guo, X., Garrett-Beal, L. & Yang, Y. Wnt\/\u03b2-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739\u2013750 (2005).","journal-title":"Dev. Cell"},{"key":"BFnrm3254_CR138","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.devcel.2005.02.013","volume":"8","author":"TP Hill","year":"2005","unstructured":"Hill, T. P., Spater, D., Taketo, M. M., Birchmeier, W. & Hartmann, C. Canonical Wnt\/\u03b2-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8, 727\u2013738 (2005).","journal-title":"Dev. Cell"},{"key":"BFnrm3254_CR139","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ydbio.2011.08.020","volume":"359","author":"KS Joeng","year":"2011","unstructured":"Joeng, K. S., Schumacher, C. A., Zylstra-Diegel, C. R., Long, F. & Williams, B. O. Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo. Dev. Biol. 359, 222\u2013229 (2011).","journal-title":"Dev. Biol."},{"key":"BFnrm3254_CR140","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1242\/dev.02546","volume":"133","author":"KK Mak","year":"2006","unstructured":"Mak, K. K., Chen, M. H., Day, T. F., Chuang, P. T. & Yang, Y. Wnt\/\u03b2-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation. Development 133, 3695\u20133707 (2006).","journal-title":"Development"},{"key":"BFnrm3254_CR141","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.devcel.2006.11.003","volume":"12","author":"X Tu","year":"2007","unstructured":"Tu, X. et al. Noncanonical Wnt signaling through G protein-linked PKC\u03b4 activation promotes bone formation. Dev. Cell 12, 113\u2013127 (2007).","journal-title":"Dev. Cell"},{"key":"BFnrm3254_CR142","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/ncb1647","volume":"9","author":"I Takada","year":"2007","unstructured":"Takada, I. et al. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-\u03b3 transactivation. Nature Cell Biol. 9, 1273\u20131285 (2007).","journal-title":"Nature Cell Biol."},{"key":"BFnrm3254_CR143","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.289.5481.950","volume":"289","author":"SE Ross","year":"2000","unstructured":"Ross, S. E. et al. Inhibition of adipogenesis by Wnt signaling. Science 289, 950\u2013953 (2000).","journal-title":"Science"},{"key":"BFnrm3254_CR144","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1083\/jcb.201008012","volume":"192","author":"J Albers","year":"2011","unstructured":"Albers, J. et al. Control of bone formation by the serpentine receptor Frizzled-9. J. Cell Biol. 192, 1057\u20131072 (2011).","journal-title":"J. Cell Biol."},{"key":"BFnrm3254_CR145","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","volume":"21","author":"XH Feng","year":"2005","unstructured":"Feng, X. H. & Derynck, R. Specificity and versatility in TGF-\u03b2 signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659\u2013693 (2005).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFnrm3254_CR146","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1371\/journal.pgen.0020216","volume":"2","author":"A Bandyopadhyay","year":"2006","unstructured":"Bandyopadhyay, A. et al. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet. 2, e216 (2006).","journal-title":"PLoS Genet."},{"key":"BFnrm3254_CR147","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/ng1916","volume":"38","author":"K Tsuji","year":"2006","unstructured":"Tsuji, K. et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nature Genet. 38, 1424\u20131429 (2006).","journal-title":"Nature Genet."},{"key":"BFnrm3254_CR148","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1242\/dev.025825","volume":"135","author":"N Kamiya","year":"2008","unstructured":"Kamiya, N. et al. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 135, 3801\u20133811 (2008).","journal-title":"Development"},{"key":"BFnrm3254_CR149","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1359\/jbmr.080809","volume":"23","author":"N Kamiya","year":"2008","unstructured":"Kamiya, N. et al. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J. Bone Miner. Res. 23, 2007\u20132017 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1359\/jbmr.090806","volume":"25","author":"N Kamiya","year":"2010","unstructured":"Kamiya, N. et al. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J. Bone Miner. Res. 25, 200\u2013210 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR151","doi-asserted-by":"crossref","first-page":"27560","DOI":"10.1074\/jbc.M404222200","volume":"279","author":"Y Mishina","year":"2004","unstructured":"Mishina, Y. et al. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J. Biol. Chem. 279, 27560\u201327566 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3254_CR152","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1210\/en.2002-220918","volume":"144","author":"RD Devlin","year":"2003","unstructured":"Devlin, R. D. et al. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 144, 1972\u20131978 (2003).","journal-title":"Endocrinology"},{"key":"BFnrm3254_CR153","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1242\/jcs.03466","volume":"120","author":"X Tan","year":"2007","unstructured":"Tan, X. et al. Smad4 is required for maintaining normal murine postnatal bone homeostasis. J. Cell Sci. 120, 2162\u20132170 (2007).","journal-title":"J. Cell Sci."},{"key":"BFnrm3254_CR154","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/83810","volume":"27","author":"A Daluiski","year":"2001","unstructured":"Daluiski, A. et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nature Genet. 27, 84\u201388 (2001).","journal-title":"Nature Genet."},{"issue":"1","key":"BFnrm3254_CR155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/me.2011-1168","volume":"26","author":"Shoichiro Kokabu","year":"2012","unstructured":"Kokabu, S. et al. BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol. Endocrinol. 10 Nov 2011 (doi:10.1210\/me.2011-1168).","journal-title":"Molecular Endocrinology"},{"key":"BFnrm3254_CR156","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/dvdy.21388","volume":"237","author":"N Itoh","year":"2008","unstructured":"Itoh, N. & Ornitz, D. M. Functional evolutionary history of the mouse Fgf gene family. Dev. Dyn. 237, 18\u201327 (2008).","journal-title":"Dev. Dyn."},{"key":"BFnrm3254_CR157","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","volume":"16","author":"VP Eswarakumar","year":"2005","unstructured":"Eswarakumar, V. P., Lax, I. & Schlessinger, J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139\u2013149 (2005).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrm3254_CR158","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gad.990702","volume":"16","author":"DM Ornitz","year":"2002","unstructured":"Ornitz, D. M. & Marie, P. J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16, 1446\u20131465 (2002).","journal-title":"Genes Dev."},{"key":"BFnrm3254_CR159","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1172\/JCI8641","volume":"105","author":"A Montero","year":"2000","unstructured":"Montero, A. et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest. 105, 1085\u20131093 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnrm3254_CR160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ydbio.2006.08.071","volume":"302","author":"Z Liu","year":"2007","unstructured":"Liu, Z., Lavine, K. J., Hung., I. H. & Ornitz, D. M. FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Dev. Biol. 302, 80\u201391 (2007).","journal-title":"Dev. Biol."},{"key":"BFnrm3254_CR161","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1101\/gad.965702","volume":"16","author":"N Ohbayashi","year":"2002","unstructured":"Ohbayashi, N. et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16, 870\u2013879 (2002).","journal-title":"Genes Dev."},{"key":"BFnrm3254_CR162","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ydbio.2006.05.031","volume":"296","author":"AL Jacob","year":"2006","unstructured":"Jacob, A. L., Smith, C., Partanen, J. & Ornitz, D. M. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev. Biol. 296, 315\u2013328 (2006).","journal-title":"Dev. Biol."},{"key":"BFnrm3254_CR163","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1242\/dev.00491","volume":"130","author":"K Yu","year":"2003","unstructured":"Yu, K. et al. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130, 3063\u20133074 (2003).","journal-title":"Development"},{"key":"BFnrm3254_CR164","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1242\/dev.129.16.3783","volume":"129","author":"VP Eswarakumar","year":"2002","unstructured":"Eswarakumar, V. P. et al. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129, 3783\u20133793 (2002).","journal-title":"Development"},{"key":"BFnrm3254_CR165","doi-asserted-by":"crossref","first-page":"12555","DOI":"10.1073\/pnas.0405031101","volume":"101","author":"VP Eswarakumar","year":"2004","unstructured":"Eswarakumar, V. P., Horowitz, M. C., Locklin, R., Morriss-Kay, G. M. & Lonai, P. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc. Natl Acad. Sci. USA 101, 12555\u201312560 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR166","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/hmg\/ddh034","volume":"13","author":"G Valverde-Franco","year":"2004","unstructured":"Valverde-Franco, G. et al. Defective bone mineralization and osteopenia in young adult FGFR3\u2212\/\u2212 mice. Hum. Mol. Genet. 13, 271\u2013284 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrm3254_CR167","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/excr.1997.3501","volume":"232","author":"F Liu","year":"1997","unstructured":"Liu, F., Malaval, L. & Aubin, J. E. The mature osteoblast phenotype is characterized by extensive plasticity. Exp. Cell Res. 232, 97\u2013105 (1997).","journal-title":"Exp. Cell Res."},{"key":"BFnrm3254_CR168","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","volume":"100","author":"P Ducy","year":"2000","unstructured":"Ducy, P. et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197\u2013207 (2000).","journal-title":"Cell"},{"key":"BFnrm3254_CR169","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","volume":"111","author":"S Takeda","year":"2002","unstructured":"Takeda, S. et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305\u2013317 (2002).","journal-title":"Cell"},{"key":"BFnrm3254_CR170","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2009.06.051","volume":"138","author":"VK Yadav","year":"2009","unstructured":"Yadav, V. K. et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138, 976\u2013989 (2009).","journal-title":"Cell"},{"key":"BFnrm3254_CR171","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/jbmr.367","volume":"26","author":"GA Williams","year":"2011","unstructured":"Williams, G. A. et al. Skeletal phenotype of the leptin receptor-deficient db\/db mouse. J. Bone Miner. Res. 26, 1698\u20131709 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR172","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1210\/endo.140.4.6637","volume":"140","author":"T Thomas","year":"1999","unstructured":"Thomas, T. et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140, 1630\u20131638 (1999).","journal-title":"Endocrinology"},{"key":"BFnrm3254_CR173","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/joe.0.1750405","volume":"175","author":"J Cornish","year":"2002","unstructured":"Cornish, J. et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol. 175, 405\u2013415 (2002).","journal-title":"J. Endocrinol."},{"key":"BFnrm3254_CR174","doi-asserted-by":"crossref","first-page":"20529","DOI":"10.1073\/pnas.0808701106","volume":"105","author":"Y Shi","year":"2008","unstructured":"Shi, Y. et al. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc. Natl Acad. Sci. USA 105, 20529\u201320533 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR175","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"RA Nissenson","year":"2008","unstructured":"Nissenson, R. A. & Juppner, H. in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (ed. Rosen, C. J.) (Wiley, 2008)."},{"key":"BFnrm3254_CR176","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/endo-110-2-506","volume":"110","author":"CS Tam","year":"1982","unstructured":"Tam, C. S., Heersche, J. N., Murray, T. M. & Parsons, J. A. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 110, 506\u2013512 (1982).","journal-title":"Endocrinology"},{"key":"BFnrm3254_CR177","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1677\/joe.1.06657","volume":"189","author":"S Yakar","year":"2006","unstructured":"Yakar, S. et al. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. J. Endocrinol. 189, 289\u2013299 (2006).","journal-title":"J. Endocrinol."},{"key":"BFnrm3254_CR178","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cmet.2009.12.007","volume":"11","author":"J Guo","year":"2010","unstructured":"Guo, J. et al. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab. 11, 161\u2013171 (2010).","journal-title":"Cell Metab."},{"key":"BFnrm3254_CR179","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","volume":"349","author":"DM Black","year":"2003","unstructured":"Black, D. M. et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N. Engl. J. Med. 349, 1207\u20131215 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrm3254_CR180","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.stem.2010.09.012","volume":"7","author":"X Wu","year":"2010","unstructured":"Wu, X. et al. Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell 7, 571\u2013580 (2010).","journal-title":"Cell Stem Cell"},{"key":"BFnrm3254_CR181","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","volume":"15","author":"Y Tang","year":"2009","unstructured":"Tang, Y. et al. TGF-\u03b21-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nature Med. 15, 757\u2013765 (2009).","journal-title":"Nature Med."},{"key":"BFnrm3254_CR182","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","volume":"29","author":"A Giustina","year":"2008","unstructured":"Giustina, A., Mazziotti, G. & Canalis, E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535\u2013559 (2008).","journal-title":"Endocr. Rev."},{"key":"BFnrm3254_CR183","doi-asserted-by":"crossref","first-page":"31666","DOI":"10.1074\/jbc.M705219200","volume":"282","author":"DJ DiGirolamo","year":"2007","unstructured":"DiGirolamo, D. J. et al. Mode of growth hormone action in osteoblasts. J. Biol. Chem. 282, 31666\u201331674 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3254_CR184","doi-asserted-by":"crossref","first-page":"44005","DOI":"10.1074\/jbc.M208265200","volume":"277","author":"M Zhang","year":"2002","unstructured":"Zhang, M. et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J. Biol. Chem. 277, 44005\u201344012 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrm3254_CR185","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1210\/endo.141.7.7585","volume":"141","author":"G Zhao","year":"2000","unstructured":"Zhao, G. et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141, 2674\u20132682 (2000).","journal-title":"Endocrinology"},{"key":"BFnrm3254_CR186","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1073\/pnas.1533500100","volume":"100","author":"H Kawano","year":"2003","unstructured":"Kawano, H. et al. Suppressive function of androgen receptor in bone resorption. Proc. Natl Acad. Sci. USA 100, 9416\u20139421 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR187","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1359\/jbmr.060103","volume":"21","author":"K Venken","year":"2006","unstructured":"Venken, K. et al. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. J. Bone Miner. Res. 21, 576\u2013585 (2006).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrm3254_CR188","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1172\/JCI200317246","volume":"111","author":"NA Sims","year":"2003","unstructured":"Sims, N. A. et al. A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J. Clin. Invest. 111, 1319\u20131327 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrm3254_CR189","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1073\/pnas.97.10.5474","volume":"97","author":"O Vidal","year":"2000","unstructured":"Vidal, O. et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc. Natl Acad. Sci. USA 97, 5474\u20135479 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm3254_CR190","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bone.2011.03.771","volume":"49","author":"FA Syed","year":"2011","unstructured":"Syed, F. A., Fraser, D. G., Monroe, D. G. & Khosla, S. Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor \u03b1 on bone. Bone 49, 208\u2013216 (2011).","journal-title":"Bone"}],"container-title":["Nature Reviews Molecular Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrm3254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrm3254","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrm3254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:01:51Z","timestamp":1684468911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrm3254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,22]]},"references-count":190,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["BFnrm3254"],"URL":"https:\/\/doi.org\/10.1038\/nrm3254","relation":{},"ISSN":["1471-0072","1471-0080"],"issn-type":[{"value":"1471-0072","type":"print"},{"value":"1471-0080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,22]]}}}